Target intelligence / Profile preview

50S bacterial ribosomal subunit (50S subunit) (50S subunit)

Target
50S subunit
Molecular classification
Enzyme, Other
01

Overview

The 50S bacterial ribosomal subunit is the larger component of the prokaryotic 70S ribosome, primarily composed of the 23S ribosomal RNA (rRNA), the 5S rRNA, and approximately 33 ribosomal proteins [1]. Its central biological role is to catalyze the formation of peptide bonds between amino acids during translation, a process mediated by the peptidyl transferase center (PTC) located within the 23S rRNA [2]. Additionally, the subunit forms the nascent peptide exit tunnel (NPET), which guides the growing polypeptide chain away from the catalytic site [3]. This subunit is a major therapeutic target for several classes of antibiotics, including macrolides, lincosamides, oxazolidinones, and pleuromutilins, which selectively bind to the rRNA to disrupt protein synthesis [4]. Because bacterial ribosomes are structurally distinct from eukaryotic 80S ribosomes, these drugs achieve selective toxicity, although their similarity to human mitochondrial ribosomes can lead to clinical side effects like myelosuppression [5]. Resistance to these agents frequently occurs through point mutations in the 23S rRNA or enzymatic modifications such as methylation, which hinder drug binding [6].

Other names
23S ribosomal RNA5S ribosomal RNALarge ribosomal subunitBacterial 50S ribosomeProkaryotic 50S subunit
02

Mechanism of action

Inhibition of bacterial protein synthesis by binding to the 23S rRNA component of the 50S subunit, which either blocks the peptidyl transferase center (PTC) to prevent peptide bond formation or obstructs the nascent peptide exit tunnel (NPET) to trigger premature dissociation of peptidyl-tRNA [4, 7].

03

Biological functions

Other
04

Disease associations

Infection
05

Safety considerations

Mitochondrial protein synthesis inhibitionMyelosuppression (e.g., thrombocytopenia with linezolid)OtotoxicityGastrointestinal dysbiosisClostridioides difficile infection risk
06

Interacting drugs

Azithromycin

11 more in the full profile.

07

Biomarkers

23S rRNA A2058/A2059 mutationserm gene methylation statuscfr gene presencerplC/rplD mutations

Beyond the preview

Go deeper on 50S bacterial ribosomal subunit (50S subunit) (50S subunit).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 50S bacterial ribosomal subunit (50S subunit) (50S subunit).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call